Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
Clinical trial NCT05769777 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05769777
- Sponsor
- Sanofi
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-03
- Primary completion
- 2031-06-11
- Enrollment
- 999
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.